PGN-EDO53

N/A

Report date: 2025/07/08 17:25:03

Base Information

Drug NamePGN-EDO53

Drug Alias NamePGN-EDO53PGN-EDO-53

ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Small molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionDystrophin stimulants

TargetsDystrophin

Therapy Area/IndicationsMuscular Dystrophy, Duchenne

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPepGen Inc

China Registration ClassN/A

Develop Information

Active CompaniesPepGen Inc

Inactive CompaniesN/A

Active IndicationsMuscular Dystrophy, Duchenne

Inactive IndicationsN/A

Other Information

ATC CodeN/A